Principles of oxygenator function: Gas exchange, heat transfer, and operation

Cardiopulmonary Bypass: Principles and Practice: Third Edition

Volumn , Issue , 2012, Pages 47-62

  Stammers, Alfred H ^a   Trowbridge, Cody C ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971012448     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Mejak BL, Stammers A, Rauch E, et al. A retrospective study on perfusion incidents and safety devices. Perfusion 2000;15:51-61.
2. Black S, Bolman RM III. C. Walton Lillehei and the birth of open heart surgery. J Card Surg 2006;21:205-208.
3. Trowbridge C, Vasquez M, Stammers AH, et al. The effects of continuous blood gas management during cardiopulmonary bypass:a prospective, randomized study-part 1. J Extra Corpor Technol 2000;32:120-128.
4. Trowbridge C, Vasquez M, Stammers AH, et al. The effects of continuous blood gas management during cardiopulmonary bypass:a prospective, randomized study-Part 2. J Extra Corpor Technol 2000;32:120-128.
5. Hsu LC. Issues of biocompatibility:heparin-coated extracorporeal circuit. Int Anesthesiol Clin 1996;34:109-122.
6. Cazzaniga A, Ranuccl M, Isgro G, et al. Trillium biopassive surface:a new biocompatible treatment for extracorporeal circulation circuits. Int J Artif Organs 2000;23:319-324.
7. Tanaka M, Motomura T, Kawada M, et al. A. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)-relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000;21:1471-1481.
8. Myers GJ, Johnstone DR, Swyer WJ, et al. Evaluation of Mimesys phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults. J Extra Corpor Technol 2003;35:6-12.
9. Marx TI, Snyder WE, St. John AD, et al. Diffusion of oxygen into a film of whole blood. J Appl Physiol 1960;15:1123-1129.
10. Zapol WM, Qvist J. Artificial lungs for acute respiratory failure. New York:Academic Press, 1976.
11. Marx TI, Baldwin BR, Miller DR. Factors influencing oxygen uptake by blood in membrane oxygenators:report of a study. Ann Surg 1962;156:204-213.
12. Gaylor JDS. Membrane oxygenators:current developments in design and application. JBiomed Eng 1988;10:541-547.
13. Bartlett RH, Kittredge D, Noyes BS Jr, et al. Development of a membrane oxygenator:overcoming blood diffusion limitation. J Thorac Cardiovasc Surg 1969;58:795-800.
14. Drinker PA, Bartlett RH, Bialer RM, et al. Augmentation of membrane gas transfer by induced secondary flows. Surgery 1969;66:775-781.
15. Kolobow T, Bowman RL. Construction and evaluation of an alveolar membrane artificial heart-lung. Trans Am Soc Artif Intern Organs 1963;9:238-243.
16. Motomura T, Maeda T, Kawahito S, et al. Development of silicone rubber hollow fiber membrane oxygenator for ECMO. Artif Organs 2003;27:1050-1053.
17. Horton S, Thuys C, Bennett M, et al. Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO. Perfusion 2004;19:17-23.
18. Murphy W, Trudell LA, Friedman LI, et al. Laboratory and clinical experience with a microporous membrane oxygenator. Trans Am Soc Artif Intern Organs 1974;20A:278-285.
19. Mottaghy K, Oedekoven H, Starmans H, et al. Technical aspects of plasma leakage prevention in microporous membrane oxygenators. Trans Am Soc ArtifIntern Organs 1989;35:640-643.
20. Gile JP, Trudell L, Snider MT, et al. Capability of the microporous membrane-lined, capillary oxygenator in hypercapnic dogs. Trans Am Soc ArtifIntern Organs 1970;16:365-374.
21. Meyns B, Vercaemst L, Vandezande E, et al. Plasma leakage of oxygenators in ECMO depends on the type of oxygenator and on patient variables. Int J Artif Organs 2005;28:30-34.
22. Eash HJ, Jones HM, Hattler BG, et al. Evaluation of plasma resistant hollow fiber membranes for artificial lungs. ASAIO J 2004;50:491-497.
23. Bierenbaum HS, Isaacson RB, Druin ML, et al. Microporous polymeric films. Ind Eng Chem Prod Res Dev 1974;13:2-9.
24. Bodell BR, Head JM, Head LR, et al. A capillary membrane oxygenator. J Thorac Cardiovasc Surg 1963;46:639-649.
25. Dutton RC, Edmunds LH Jr. Formation of platelet aggregate emboli in a prototype hollow-fiber membrane oxygenator. J Biomed Mater Res 1974;8:163.
26. Goodin MS, Thor EJ, Haworth WS. Use of computational fluid dynamics in the design of the Avecor Affinity oxygenator. Perfusion 1994;9:217-222.
27. Stammers AH. Monitoring controversies during cardiopulmonary bypass:how far have we come. Perfusion 1998;13:35-43.
28. Schreur A, Niles S, Ploessl J. Use of the CDI blood parameter monitoring system 500 for continuous blood gas measurement during extracorporeal membrane oxygenation simulation. J Extra Corpor Technol 2005;37:377-380.
29. Quinn RD, Pae WE, McGary SA, et al. Development of malignant hyperthermia during mitral valve replacement. Ann Thorac Surg 1992;53:1114-1116.
30. Fried DW, DeBenedetto BN, Leo JJ. Rethinking the AAMI/ISO "International standard" for oxygen transfer performance of artificial lungs. Perfusion 1994;9:335-342.
31. Fried DW. Performance evaluation of blood-gas exchange devices. Int Anesthesiol Clin 1996;34:47-60.
32. Ueyama K, Niimi Y, Nose Y. How to test oxygenators for extracorporeal membrane oxygenation:is the Association for the Advancement of Medical Instrumentation's protocol enough? Artif Organs 1996;20:741-742.
33. Holman JP. Heat transfer. New York:McGraw-Hill, 1972.
34. Grigore AM, Grocott HP, Mathew JP, et al. Neurologic Outcome Research Group of the Duke Heart Center. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg 2002;94:4-10.
35. Nathan HJ, Lavallee G. The management of temperature during hypothermic cardiopulmonary bypass. I. Canadian survey [comments]. Can J Anaesth 1995;42:663-668.
36. Cook DJ, Orszulak TA, Daly RC, et al. Cerebral hyperthermia during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:268-269.
37. Kmiecik SA, Liu JL, Vaadia TS, et al. Quantitative evaluation of hypothermia, hyperthermia, and hemodilution on coagulation. J Extra Corpor Technol 2001;33:100-105.
38. Jenkins I, Karliczek G, de Geus F, et al. Postbypass hypothermia and its relationship to the energy balance of cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1991;5:135-138.
39. Davis FM, Parumelazhagan KN, Harris EA. Thermal balance during cardiopulmonary bypass with moderate hypothermia in man. Br J Anaesth 1977;49:1127-1132.
40. Mendelowitz M. The specific heat of human blood. Science 1948;107:97-98.
41. Elahi MM, Khan JS, Matata BM. Deleterious effects of cardiopulmonary bypass in coronary artery surgery and scientific interpretation of off-pump's logic. Acute Card Care 2006;8:196-209.
42. Gott VL, Whiffen JD, Datton RC. Heparin surface bonding on colloidal graphite surface. Science 1963;142:1297-1298.
43. Mahoney CB. Heparin-bonded circuits:clinical outcomes and costs. Perfusion 1998;13:192-204.
44. Stammers AH, Christensen KA, Lynch J, et al. Quantitative evaluation of heparin coated versus non heparin coated bypass circuits during cardiopulmonary bypass. J Extra Corpor Technol 1999;31:135-141.
45. Jansen PGM, te Velthuis H, Huybregts RAJM, et al. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin coated circuits. J Thorac Cardiovasc Surg 1995;110:829-834.
46. Zimmermann AK, Weber N, Aebert H, et al. Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators. J Biomed Mater Res B Appl Biomater 2007;80:433-439.
47. Gorman RC, Ziats N, Rao AK, et al. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;111:1-11.
48. van den Goor JM, van Oeveren W, Rutten PM, et al. Adhesion of thrombotic components to the surface of a clinically used oxygenator is not affected by Trillium coating. Perfusion 2006;21:165-172.
49. Ereth MH, Nuttall GA, Clarke SH Jr, et al. Biocompatibility of trillium biopassive surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2001;15:545-550.
50. Goudeau JJ, Clermont G, Guillery O, et al. In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J Cardiovasc Pharmacol 2007;49:39-45.
51. Trowbridge CC, Stammers AH, Wood GC, et al. Improved outcomes during cardiac surgery:a multifactorial enhancement of cardiopulmonary bypass techniques. J Extra Corpor Technol 2005;37:165-172.
52. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-755.
53. Lilly KJ, O'Gara PJ, Treanor PR, et al. Heparin-bonded circuits without a cardiotomy:a description of a minimally invasive technique of cardiopulmonary bypass. Perfusion 2002;17:95-97.
54. Pierce ML, Stammers AH, Dickes MS, et al. Is fibrinolytic activity stimulated during cardiopulmonary bypass from blood exposed to pleural surfaces? J Extra Corpor Technol 1998;30:120-126.
55. De Somer F, Van Belleghem Y, Caes F, et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002;123:951-958.
56. Carrier M, Denault A, Lavoie J, et al. Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery. Ann Thorac Surg 2006;82:51-55.
57. Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 2004;78:54-59.
58. Skrabal CA, Khosravi A, Choi YH, et al. Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass. Scand Cardiovasc J 2006;40:219-223.
59. Westerberg M, Gabel J, Bengtsson A, et al. Hemodynamic effects of cardiotomy suction blood. J Thorac Cardiovasc Surg 2006;131:1352-1357.
60. Pierangeli A, Masieri V, Bruzzi F, et al. Haemolysis during cardiopulmonary bypass:how to reduce the free haemoglobin by managing the suctioned blood separately. Perfusion 2001;16:519-524.
61. Abdel-Rahman U, Martens S, Risteski P, et al. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis-a randomized clinical study. Heart Surg Forum 2006;9:E543-E548.
62. Abdel-Rahman U, Ozaslan F, Risteski PS, et al. Initial experience with a minimized extracorporeal bypass system:is there a clinical benefit? Ann Thorac Surg 2005;80:238-243.
63. Bein B, Caliebe D, Scholz J, et al. A new cardiopulmonary bypass circuit with reduced foreign surface (CorX):initial clinical experience and implications for anaesthesia management. Eur J Anaesthesiol 2004;21:982-984.
64. Nollert G, Schwabenland I, Maktav D, et al. Miniaturized cardiopulmonary bypass in coronary artery bypass surgery:marginal impact on inflammation and coagulation but loss of safety margins. Ann Thorac Surg 2005;80:2326-2332.REFERENCES.